Abstract
Response to: Ferenci T. Absolute risk reduction may depend on the duration of the follow-up. Expert Rev Clin Pharmacol. 2017;10(12):1409-1410.
MeSH terms
-
Deception
-
Follow-Up Studies
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
-
Numbers Needed To Treat
-
Research
Substances
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors